Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concentrated Citrate Locking to Reduce the Incidence of Central Venous Catheter-related Infections and Thrombosis: a Randomized Phase III Study in a Hematological Patient Population

NCT01820962 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01820962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01820962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concentrated Citrate Locking to Reduce the Incidence of Central Venous Catheter-related Infections and Thrombosis: a Randomized Phase III Study in a Hematological Patient Population
Lead sponsor
Maastricht University Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2006
Completion date
July 31, 2012
Enrollment
212 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, hematological malignancies, thrombosis